BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Year-over-year debt growth rate
3Y CAGR
+219.7%/yr
vs -26.5%/yr prior
Acceleration
+246.2pp
Accelerating
Percentile
P95
Near historical high
vs 3Y Ago
32.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.39% |
| Q3 2025 | 0.06% |
| Q2 2025 | 0.32% |
| Q1 2025 | -0.12% |
| Q4 2024 | 0.00% |
| Q3 2024 | -45.19% |
| Q2 2024 | 0.28% |
| Q1 2024 | 0.07% |
| Q4 2023 | 0.04% |
| Q3 2023 | 0.18% |
| Q2 2023 | 0.00% |
| Q1 2023 | -0.01% |
| Q4 2022 | 0.20% |
| Q3 2022 | -0.04% |
| Q2 2022 | 0.07% |
| Q1 2022 | 0.12% |
| Q4 2021 | 0.16% |
| Q3 2021 | -0.04% |
| Q2 2021 | 0.07% |
| Q1 2021 | 0.04% |
| Q4 2020 | -25.52% |
| Q3 2020 | 0.32% |
| Q2 2020 | 68.55% |
| Q1 2020 | 0.50% |
| Q4 2019 | 0.58% |
| Q3 2019 | 0.53% |
| Q2 2019 | 0.63% |
| Q1 2019 | 1.63% |
| Q4 2018 | -30.82% |
| Q3 2018 | 0.73% |
| Q2 2018 | 0.73% |
| Q1 2018 | 0.73% |
| Q4 2017 | 0.72% |
| Q3 2017 | 72.44% |
| Q2 2017 | -2.13% |
| Q1 2017 | 1.13% |
| Q4 2016 | 1.13% |
| Q3 2016 | 0.83% |
| Q2 2016 | 0.31% |
| Q1 2016 | 0.86% |